Geode Capital Management’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.07M Buy
754,499
+197,544
+35% +$1.99M ﹤0.01% 2742
2026
Q2
$7.27M Buy
556,955
+283,024
+103% +$2.89M ﹤0.01% 2715
2026
Q1
$2.9M Buy
+273,931
New +$3.66M ﹤0.01% 2986

Other funds holding EIKN

Geode Capital Management's EIKN Position: Q3 2026 in Review

Geode Capital Management increased its Eikon Therapeutics (EIKN) stake by 35% in Q3 2026, buying an estimated $1.99M and bringing the position to 754,499 shares worth $6.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

Geode Capital Management first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.27M in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Geode Capital Management held 754,499 shares of Eikon Therapeutics worth $6.07M as of Q3 2026.
  • Geode Capital Management bought 197,544 Eikon Therapeutics shares in Q3 2026, an estimated $1.99M.
  • Eikon Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2742 holding.
  • Geode Capital Management first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Geode Capital Management's Eikon Therapeutics position peaked at $7.27M in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.